Clinical trials: Overactivity; Behavior
ADHD
Neurofeedback Study ADHD
Neurofeedback has proved to be effective in treating Attention deficit hyperactivity disorder (ADHD) in experimental settings. This study investigates whether neurofeedback can be used as a therapeutic intervention in regular…
- Trial name
- NCT01879644
- Testing
- NF, SM, PE
- Where
- Germany
- Volunteers
- 120 people
- Sponsor
- Philipps University Marburg
Attention Deficit Hyperactivity Disorder, Psychiatric Diagnosis
Neurophysiological Marker of ADHD in Children
This study investigated quantitative electroencephalography (QEEG) subtypes as auxiliary tools to assess Attention Deficit Hyperactivity Disorder (ADHD).
- Conditions
- Attention Deficit Hyperactivity Disorder, Psychiatric Diagnosis, Diagnosis, Psychiatric
- Trial name
- NCT04467658
- Testing
- electroencephalography absolute delta power, electroencephalography relative delta power, electroencephalography absolute theta power
- Where
- South Korea
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Daegu Catholic University Medical Center
Attention Deficit Hyperactivity Disorder
Transcranial Magnetic Stimulation in Children With Attention Deficit Hyperactivity Disorder (ADHD). A Safety Study
Low frequency repetitive Transcranial Magnetic Stimulation(rTMS) is a safe and tolerable procedure in children with Attention Deficit Hyperactivity Disorder(ADHD); it also could be a complement to the treatment of patients with…
- Trial name
- NCT01052064
- Testing
- Transcranial Magnetic Stimulation
- Where
- Cuba
- Volunteers
- 20 people
- Sponsor
- International Center for Neurological Restoration, Cuba
Attention Deficit Hyperactivity Disorder
A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD
Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder that presents during childhood, with at least some symptoms causing impairment before the age of seven.
- Trial name
- NCT02086864
- Testing
- lactose/sucrose granule (Individualized homeopathic medicine treatment), Homeopathic consultation
- Where
- Canada
- Volunteers
- 151 people
- Sponsor
- University of Toronto
Attention Deficit Hyperactivity Disorder, Youths
Study of the Link Between Psychosocial Treatments and the Need of Pharmacological Treatments in Children With Attention Deficit Hyperactivity Disorder
The Attention Deficit and Hyperactivity Disorder (ADHD) is a frequent disorder in children and adolescents. The diagnosis is clinical with the input of several informants (child, family, teachers, …).
- Trial name
- OPTIME-TDAH (NCT04412499)
- Where
- France
- Volunteers
- 110 people
- Sponsor
- University Hospital, Montpellier
ADHD, Executive Function
Effectiveness of the Indonesian Computer-based Game
The aim of this study was to develop an Indonesian computer-based game prototype that targets the clinical symptoms of ADHD as well as executive function and to investigate effectiveness through fMRI BOLD examination.
- Trial name
- NCT04329663
- Testing
- Indonesian computer-based game prototype
- Where
- Indonesia
- Volunteers
- 10 people
- Sponsor
- Tjhin Wiguna
Attention Deficit Hyperactivity Disorder (ADHD), ADHD
Effects of Phosphatidylserine and DHA on Cognitive Performance in Children With ADHD
This study aimed to evaluate the effects of different phosphatidylserine (PS) formulations, with or without docosahexaenoic acid (DHA), on cognitive performance in children diagnosed with attention-deficit/hyperactivity disorder…
- Trial name
- PS-DHA-ADHD (NCT07521449)
- Testing
- Phosphatidylserine-Omega3, DHA Omega-3
- Where
- Turkey (Türkiye)
- Volunteers
- 45 people
- Sponsor
- Çağlar Charles Daniel Jaicks
Attention Deficit and Disruptive Behavior Disorders, Problem Behavior
Effectiveness of Behavioral Preschool Teacher Training for Externalizing
A cluster randomized controlled pre-post effectiveness trial of behavioral preschool teacher training (BPTT) delivered in a practitioner assisted group format for children with externalizing behavior problems.
- Conditions
- Attention Deficit and Disruptive Behavior Disorders, Problem Behavior, Attention Deficit Disorder With Hyperactivity
- Trial name
- BPTT (NCT03967509)
- Testing
- Comet
- Where
- Sweden
- Volunteers
- 100 people
- Sponsor
- Uppsala University
Autism, Autism Spectrum Disorder (ASD)
ScanBrit Dietary Intervention in Autism
A growing body of research indicates that dietary intervention excluding foods containing the proteins, gluten and casein, from the diet of children diagnosed with an autism spectrum disorder (ASD) may have a positive effect on…
- Trial name
- ScanBrit (NCT00614198)
- Testing
- Gluten- and casein-free diet
- Volunteers
- 72 people
- Sponsor
- Center for Autisme, Denmark
Attention-Deficit/Hyperactivity Disorder
Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD
The purpose of this study is to assess the efficacy, safety and tolerability of atomoxetine administered once daily in the treatment of adolescents with ADHD after 8 weeks and after 52 weeks
- Trial name
- NCT00191035
- Testing
- Atomoxetine
- Where
- 21 sites in United States
- Volunteers
- 520 people
- Sponsor
- Eli Lilly and Company
ADHD
RCT of EF Family Training for P ADHD
To explore the effect of executive function family training for preschool children with ADHD, providing early social psychological intervention for aiming the core impairments of ADHD.
- Trial name
- NCT04454008
- Testing
- executive function family training, treat as usual
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Depression, Anorexia Nervosa
Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
The investigators aim to analyse in adolescents with mental illness effectiveness, side effects, and serum level concentrations of antipsychotics (olanzapine and aripiprazole), antidepressants (Duloxetine, Atomoxetine) by means…
- Conditions
- Depression, Anorexia Nervosa, ADHD
- Trial name
- TDMKJP (NCT01057329)
- Testing
- Atomoxetine, Duloxetine, Olanzapine
- Where
- Austria
- Volunteers
- 200 people
- Sponsor
- Medical University of Vienna
Attention Deficit Disorder With Hyperactivity, Methylphenidate
Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)
The noradrenergic system plays a known role in attentional systems and suspected causal role in attention deficit/hyperactivity disorder(ADHD).Methylphenidate also has been suspected as a inhibitor of norepinephrine…
- Conditions
- Attention Deficit Disorder With Hyperactivity, Methylphenidate, Pharmacogenetics
- Trial name
- NETADHD (NCT00757029)
- Testing
- norepinephrine transporter polymorphism,
- Where
- South Korea
- Volunteers
- 150 people
- Sponsor
- Hallym University Medical Center
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder
Near Infrared Spectroscopy in Children With Autism and ADHD
Background: Near-infrared spectroscopy (NIRS) is a functional imaging technique that can be uses light to study brain function while allowing for movement.
- Conditions
- Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Autism
- Trial name
- NCT01730079
- Where
- United States
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- National Institute of Mental Health (NIMH)
Attention Deficit Hyperactivity Disorder
Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)
Attention deficit hyperactivity disorder (ADHD) is the most common behavior disorder, with the prevalence of 3% to 6% in children and adolescents. The patients' academic achievements, professions and social livings are impaired.
- Trial name
- NCT01339286
- Testing
- atomoxetine
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Peking University
Attention Deficit Disorder With Hyperactivity
Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
The purpose of this study is to determine whether CLONICEL® (clonidine HCl sustained release) is a safe and effective treatment for children and adolescents with attention deficit hyperactivity disorder (ADHD).
- Trial name
- NCT00556959
- Testing
- high dose clonidine HCl sustained release, low dose clonidine HCl sustained release
- Where
- 13 sites in United States
- Volunteers
- 236 people
- Sponsor
- Addrenex Pharmaceuticals, Inc.
Tourette Syndrome
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
OBJECTIVES: I. Evaluate the safety and efficacy of the alpha-2 adrenergic agonist guanfacine in children and adolescents with Tourette syndrome or other chronic tic disorder, and attention deficit hyperactivity disorder.
- Trial name
- NCT00004376
- Testing
- guanfacine
- Volunteers
- 35 people
- Sponsor
- National Center for Research Resources (NCRR)
Attention Deficit Hyperactivity Disorder
Effects of Music on Motor Skills of Children With Attention Deficit and Hyperactivity Disorder
Physiotherapists have positive effects on motor skills, executive functions and symptoms of children with attention deficit and hyperactivity disorder. However, progression takes time due to the symptoms of the disease.
- Trial name
- NCT05902338
- Testing
- Music
- Where
- Cyprus
- Volunteers
- 56 people
- Sponsor
- Eastern Mediterranean University
Attention Deficit Disorder With Hyperactivity
Adaptive Response to Intervention (RTI) for Students With ADHD
Purpose: The primary purpose of the proposed project is to investigate the efficacy of Tier 1 and Tier 2 interventions delivered through a Response to Intervention (RTI) framework for children with attention-deficit/hyperactivity…
- Trial name
- NCT03511976
- Testing
- Tier 1 Classroom Management, Daily Report Card (DRC), Enhanced DRC (DRC-E)
- Where
- 2 sites in United States
- Sponsor
- Florida International University
ADHD, Autism
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A study to assess pharmacokinetics, safety and tolerability of brexpiprazole in children ages 6 to <13 years with CNS disorders.
- Conditions
- ADHD, Autism, Bipolar I Disorder, Conduct Disorder
- Trial name
- NCT03292848
- Testing
- Brexpiprazole
- Where
- 9 sites in United States
- Volunteers
- 24 people
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.